about
Executive Summary: Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart AssociationHeart Disease and Stroke Statistics--2015 Update: A Report From the American Heart AssociationHigh-resolution magnetic resonance imaging: an emerging tool for evaluating intracranial arterial diseaseThe challenge of stroke prevention with intracranial arterial stenosisGuidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke associationHeart disease and stroke statistics--2011 update: a report from the American Heart AssociationHeart disease and stroke statistics--2014 update: a report from the American Heart AssociationCurrent Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosis.Risk factors associated with severity and location of intracranial arterial stenosis.An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.Intracranial atherosclerosis: correlation between in-vivo 3T high resolution MRI and pathology.Collaterals dramatically alter stroke risk in intracranial atherosclerosis.Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysisStroke in pregnancy.Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID?Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial.Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial.Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS).Characterization of intracranial atherosclerotic stenosis using high-resolution MRI study--rationale and design.Treatment of atherosclerotic intracranial arterial stenosis.Stenting versus aggressive medical therapy for intracranial arterial stenosis.Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial.Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial.Response to critique of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial by Abou-Chebl and Steinmetz.Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis.Intracranial stenting: SAMMPRIS.Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatmentCurrent status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting.Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association.Comparison of endovascular treatment approaches for acute ischemic stroke: cost effectiveness, technical success, and clinical outcomes.Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial.Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial.Racial differences in poststroke rehabilitation utilization and functional outcomes.Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association.
P50
Q22241920-5E2C769B-3E17-4339-BB99-EF51095DA3CBQ22241921-9FD3711D-D2EF-45F2-BD9E-A266CEC4A33AQ26863518-BE6B69BA-4538-429B-A087-9E649FC8DEFAQ27010215-1102BA2A-0AC1-4D3D-8F08-AB76F9345D4AQ28296349-931EC02D-8C68-4B72-97D3-D2D0631AED58Q29547236-97270723-4520-4DB4-B9F5-8B2696B834CEQ29547691-D336B51F-9A43-4E7F-984C-D0687B530747Q33444729-202B63CC-216E-4B0F-85BE-5357EE1A53B1Q34076214-730379C0-4B99-4E2E-B002-CB82206A4BB0Q34081399-A5621816-0974-418D-B48D-3945FCDDBE6BQ34343431-01156B58-9A7A-4FAD-8343-623A07AF93F6Q34505315-E9FD6B37-7177-4C73-BB3E-81F2D0E096F6Q34674547-9EA3587A-5774-407A-8780-30B72C44803FQ35053476-87DC4D27-046F-4745-AFBD-F3BBF659D2BCQ35126194-D5CFA8AD-7AD3-45FD-BB28-8A0E302E9B46Q35913472-A45BB2F6-D565-461D-A1B7-214F267199C4Q35998370-15E78B94-9BA2-41AE-A49A-9FEE04315068Q36219939-4F2C9879-137C-4E68-9126-F3B773AAF1ECQ36405076-8D650C6E-78BC-434B-8FFC-3688426285F8Q36405866-F52011BD-A3AA-4A07-B8BA-611755972190Q36423281-CAC7FE66-3EE7-42FB-BFD6-920FFD7E9351Q36433515-9FEBF07A-8833-4C5F-9FEE-8D8E1C6A00C6Q36467319-4E2C8FEF-F883-47A4-AFA7-A7C717B3AF43Q36509467-0FFA5D76-4B8A-49A5-B476-F8EA546CDCBFQ36555224-C669B546-455C-47FD-BE37-896BF113040DQ36840550-41C134AA-2A57-4669-82BE-1211B239983AQ36965972-F9F19754-39B5-4266-8197-86EA89435D72Q37108969-1C69B179-C840-447E-BC97-0A7E86356053Q37223863-062E1917-B7CE-4466-A7C6-40F3421DDDE1Q37267873-799690C6-0E62-4D83-BA6D-89CCB732B76EQ37677096-A8B16C61-1330-4634-B173-A1443DEEBEC0Q37710110-5570526F-19E7-4097-AB18-79AA375D561AQ37734702-C2036A4D-4082-428A-AD93-77DACFCAB801Q37945129-1EA5EE02-5051-47D7-9D15-FDE4246CED0EQ38071269-F94CB00B-CBE8-44EF-A0B0-2E2405942AE7Q38230006-899669F7-1F80-43E1-9445-A07CBA4EB23DQ38397492-4F89253F-6F22-4AE8-A09D-59DFA8BD87F4Q38399113-9E2B2958-AB25-4D5A-BA01-7845649DE278Q39128802-F14E29A9-9C8A-4878-951F-CF01F61ADADDQ40061255-A42BE1DE-EE2A-41B3-BD47-34A5ABDD44CC
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tanya Turan
@ast
Tanya Turan
@en
Tanya Turan
@es
Tanya Turan
@nl
Tanya Turan
@sl
type
label
Tanya Turan
@ast
Tanya Turan
@en
Tanya Turan
@es
Tanya Turan
@nl
Tanya Turan
@sl
prefLabel
Tanya Turan
@ast
Tanya Turan
@en
Tanya Turan
@es
Tanya Turan
@nl
Tanya Turan
@sl
P106
P1153
8044142400
P21
P31
P496
0000-0001-5399-8845